Faggot cells in therapy‐related acute myeloid leukemia with inv(16)

by Ana Vega González de Viñaspre, Carlos De Miguel Sánchez, Diego Robles De Castro, Verónica Roldán Galiacho, Arantza Mendizabal Abad, José María Guinea De Castro
Published 2021-01-01

Impact of the subcutaneous formulations of trastuzumab and rituximab on efficiency and resource optimization in Spanish hospitals: H-Excelencia study

by María Reyes Abad-Sazatornil, Ainhoa Arenaza, Juan Bayo, Jesus García Mata, José María Guinea De Castro, Josefa León, Javier Letellez, Virginia Reguero, Carmen Martínez Chamorro, Antonio Salar
Published 2021-04-01

Management of Adult Patients with Primary Immune Thrombocytopenia (ITP) in Clinical Practice: A Consensus Approach of the Spanish ITP Expert Group

by M. Eva Mingot-Castellano, M. Teresa Álvarez Román, Luis Fernando Fernández Fuertes, Tomás José González-López, José María Guinea de Castro, Isidro Jarque, M. Fernanda López-Fernández, Maria Luisa Lozano, Blanca Sánchez González, David Valcárcel Ferreiras, José Ramón González Porras
Published 2019-01-01

R‐COMP versus R‐CHOP as first‐line therapy for diffuse large B‐cell lymphoma in patients ≥60 years: Results of a randomized phase 2 study from the Spanish GELTAMO group

by Juan‐Manuel Sancho, Rubén Fernández‐Alvarez, Francisco Gual‐Capllonch, Esther González‐García, Carlos Grande, Norma Gutiérrez, María‐Jesús Peñarrubia, Ana Batlle‐López, Eva González‐Barca, José‐María Guinea, Eva Gimeno, Francisco‐Javier Peñalver, Miguel Fuertes, Mariana Bastos, José‐Ángel Hernández‐Rivas, José‐María Moraleda, Olga García, Marc Sorigué, Alejandro Martin
Published 2021-02-01